Trial Profile
A trial of sitagliptin to study effects on inflammation markers and cell adhesion molecules in type 2 diabetic patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Dec 2015
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 01 Dec 2015 New trial record